BTIG Maintains Buy on Boston Scientific, Lowers Price Target to $56
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsPrice TargetHot
BTIG analyst Marie Thibault maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $60 to $56.
BTIG analyst Marie Thibault maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $60 to $56.